Wong WL, Su X, Li X, Cheung CM, Klein R, Cheng CY, et al. Global prevalence of age-related macular degeneration and disease burden projection for 2020 and 2040: a systematic review and meta-analysis. Lancet Glob Health. 2014;2(2):e106–16.

PubMed  Article  Google Scholar 

Bakri SJ, Thorne JE, Ho AC, Ehlers JP, Schoenberger SD, Yeh S, et al. Safety and efficacy of anti-vascular endothelial growth factor therapies for neovascular age-related macular degeneration: a report by the American Academy of Ophthalmology. Ophthalmology. 2019;126(1):55–63.

PubMed  Article  Google Scholar 

Maruyama-Inoue M, Sato S, Yamane S, Kadonosono K. Variable response of subretinal hyperreflective material to anti-vascular endothelial growth factor classified with optical coherence tomography angiography. Graefes Arch Clin Exp Ophthalmol. 2018;256(11):2089–96.

CAS  PubMed  Article  Google Scholar 

Wu Q, Chen X, Feng K, Liu Y, Zhang C, Zhao L. Evaluation of efficacy and recurrence for anti-vascular endothelial growth factor therapy in idiopathic choroidal neovascularization. BMC Ophthalmol. 2020;20(1):115.

CAS  PubMed  PubMed Central  Article  Google Scholar 

Mettu PS, Allingham MJ, Cousins SW. Incomplete response to anti-VEGF therapy in neovascular AMD: exploring disease mechanisms and therapeutic opportunities. Prog Retin Eye Res. 2021;82:100906.

CAS  PubMed  Article  Google Scholar 

Budzinskaya MV, Plyukhova AA, Sorokin PA. Anti-VEGF therapy resistance in neovascular age-related macular degeneration. Vestn Oftalmol. 2017;133(4):103–8.

CAS  PubMed  Article  Google Scholar 

Kuroda Y, Yamashiro K, Miyake M, Yoshikawa M, Nakanishi H, Oishi A, et al. Factors associated with recurrence of age-related macular degeneration after anti-vascular endothelial growth factor treatment: a retrospective cohort study. Ophthalmology. 2015;122(11):2303–10.

PubMed  Article  Google Scholar 

Ashraf M, Souka A, Adelman RA. Age-related macular degeneration: using morphological predictors to modify current treatment protocols. Acta Ophthalmol. 2018;96(2):120–33.

CAS  PubMed  Article  Google Scholar 

Ying GS, Maguire MG, Daniel E, Ferris FL, Jaffe GJ, Grunwald JE, et al. Association of baseline characteristics and early vision response with 2-year vision outcomes in the comparison of AMD treatments trials (CATT). Ophthalmology. 2015;122(12):2523-31.e1.

PubMed  Article  Google Scholar 

Subhi Y, Sørensen TL. Neovascular age-related macular degeneration in the very old (≥90 years): epidemiology, adherence to treatment, and comparison of efficacy. J Ophthalmol. 2017;2017:7194927.

PubMed  PubMed Central  Article  CAS  Google Scholar 

Shin HJ, Chung H, Kim HC. Association between foveal microstructure and visual outcome in age-related macular degeneration. Retina. 2011;31(8):1627–36.

PubMed  Article  Google Scholar 

Kwon YH, Lee DK, Kim HE, Kwon OW. Predictive findings of visual outcome in spectral domain optical coherence tomography after ranibizumab treatment in age-related macular degeneration. Korean J Ophthalmol. 2014;28(5):386–92.

PubMed  PubMed Central  Article  Google Scholar 

Lee H, Lee M, Kim MA, Chung H, Kim HC. Association of treatment response with quantitative changes in choroidal neovascularization and choroidal vessel in neovascular age-related macular degeneration. Retina. 2020;40(9):1704–18.

CAS  PubMed  Article  Google Scholar 

Asai T, Ikuno Y, Nishida K. Macular microstructures and prognostic factors in myopic subretinal hemorrhages. Invest Ophthalmol Vis Sci. 2014;55(1):226–32.

PubMed  Article  Google Scholar 

Abdelfattah NS, Zhang H, Boyer DS, Rosenfeld PJ, Feuer WJ, Gregori G, et al. Drusen volume as a predictor of disease progression in patients with late age-related macular degeneration in the fellow eye. Invest Ophthalmol Vis Sci. 2016;57(4):1839–46.

CAS  PubMed  Article  Google Scholar 

Costanzo E, Miere A, Querques G, Capuano V, Jung C, Souied EH. Type 1 choroidal neovascularization lesion size: indocyanine green angiography versus optical coherence tomography angiography. Invest Ophthalmol Vis Sci. 2016;57(9):307–13.

Article  CAS  Google Scholar 

Perrott-Reynolds R, Cann R, Cronbach N, Neo YN, Ho V, McNally O, et al. The diagnostic accuracy of OCT angiography in naive and treated neovascular age-related macular degeneration: a review. Eye (Lond). 2019;33(2):274–82.

Article  Google Scholar 

Giorno P, Iacono P, Scarinci F, Di Renzo A, Varano M, Parravano M. Microvasculature changes of myopic choroidal neovascularization and the predictive value of feeder vessel disappearance after ranibizumab treatment revealed using optical coherence tomography angiography. Ophthalmologica. 2020;243(4):263–70.

CAS  PubMed  Article  Google Scholar 

Keiner CM, Zhou H, Zhang Q, Wang RK, Rinella NT, Oldenburg CE, et al. Quantifying choriocapillaris hypoperfusion in patients with choroidal neovascularization using swept-source OCT angiography. Clin Ophthalmol. 2019;13:1613–20.

PubMed  PubMed Central  Article  Google Scholar 

Kuehlewein L, Bansal M, Lenis TL, Iafe NA, Sadda SR, Bonini Filho MA, et al. Optical coherence tomography angiography of type 1 neovascularization in age-related macular degeneration. Am J Ophthalmol. 2015;160(4):739-48.e2.

PubMed  Article  Google Scholar 

Spaide RF. Optical coherence tomography angiography signs of vascular abnormalization with antiangiogenic therapy for choroidal neovascularization. Am J Ophthalmol. 2015;160(1):6–16.

PubMed  Article  Google Scholar 

Muakkassa NW, Chin AT, de Carlo T, Klein KA, Baumal CR, Witkin AJ, et al. Characterizing the effect of anti-vascular endothelial growth factor therapy on treatment-naive choroidal neovascularization using optical coherence tomography angiography. Retina. 2015;35(11):2252–9.

CAS  PubMed  Article  Google Scholar 

Amoaku WM, Chakravarthy U, Gale R, Gavin M, Ghanchi F, Gibson J, et al. Defining response to anti-VEGF therapies in neovascular AMD. Eye (Lond). 2015;29(6):721–31.

CAS  Article  Google Scholar 

Roberts PK, Schranz M, Motschi A, Desissaire S, Hacker V, Pircher M, et al. Morphologic and microvascular differences between macular neovascularization with and without subretinal fibrosis. Transl Vis Sci Technol. 2021;10(14):1.

PubMed  PubMed Central  Article  Google Scholar 

Roberts PK, Nesper PL, Gill MK, Fawzi AA. Semiautomated quantitative approach to characterize treatment response in neovascular age-related macular degeneration: a real-world study. Retina. 2017;37(8):1492–8.

PubMed  PubMed Central  Article  Google Scholar 

Moons KG, de Groot JA, Bouwmeester W, Vergouwe Y, Mallett S, Altman DG, et al. Critical appraisal and data extraction for systematic reviews of prediction modelling studies: the CHARMS checklist. PLoS Med. 2014;11(10):e1001744.

PubMed  PubMed Central  Article  Google Scholar 

Pavlou M, Ambler G, Seaman SR, De Iorio M, Omar RZ. Review and evaluation of penalised regression methods for risk prediction in low-dimensional data with few events. Stat Med. 2016;35(7):1159–77.

PubMed  Article  Google Scholar 

Yamashiro K, Tomita K, Tsujikawa A, Nakata I, Akagi-Kurashige Y, Miyake M, et al. Factors associated with the response of age-related macular degeneration to intravitreal ranibizumab treatment. Am J Ophthalmol. 2012;154(1):125–36.

CAS  PubMed  Article  Google Scholar 

Chae B, Jung JJ, Mrejen S, Gallego-Pinazo R, Yannuzzi NA, Patel SN, et al. Baseline predictors for good versus poor visual outcomes in the treatment of neovascular age-related macular degeneration with intravitreal anti-VEGF therapy. Invest Ophthalmol Vis Sci. 2015;56(9):5040–7.

CAS  PubMed  Article  Google Scholar 

Roberts PK, Zotter S, Montuoro A, Pircher M, Baumann B, Ritter M, et al. Identification and quantification of the angiofibrotic switch in neovascular AMD. Invest Ophthalmol Vis Sci. 2019;60(1):304–11.

PubMed  Article  Google Scholar 

Daniel E, Pan W, Ying GS, Kim BJ, Grunwald JE, Ferris FL 3rd, et al. Development and course of scars in the comparison of age-related macular degeneration treatments trials. Ophthalmology. 2018;125(7):1037–46.

PubMed  Article  Google Scholar 

Daniel E, Toth CA, Grunwald JE, Jaffe GJ, Martin DF, Fine SL, et al. Risk of scar in the comparison of age-related macular degeneration treatments trials. Ophthalmology. 2014;121(3):656–66.

PubMed  Article  Google Scholar 

Zhang Q, Zhang A, Lee CS, Lee AY, Rezaei KA, Roisman L, et al. Projection artifact removal improves visualization and quantitation of macular neovascularization imaged by optical coherence tomography angiography. Ophthalmol Retina. 2017;1(2):124–36.

CAS  PubMed  PubMed Central  Article  Google Scholar 

El Ameen A, Cohen SY, Semoun O, Miere A, Srour M, Quaranta-El Maftouhi M, et al. Type 2 neovascularization secondary to age-related macular degeneration imaged by optical coherence tomography angiography. Retina. 2015;35(11):2212–8.

PubMed  Article  Google Scholar 

Xu D, Dávila JP, Rahimi M, Rebhun CB, Alibhai AY, Waheed NK, et al. Long-term progression of type 1 neovascularization in age-related macular degeneration using optical coherence tomography angiography. Am J Ophthalmol. 2018;187:10–20.

PubMed  Article  Google Scholar 

Bellou S, Pentheroudakis G, Murphy C, Fotsis T. Anti-angiogenesis in cancer therapy: hercules and hydra. Cancer Lett. 2013;338(2):219–28.

CAS  PubMed  Article  Google Scholar 

Coscas F, Lupidi M, Boulet JF, Sellam A, Cabral D, Serra R, et al. Optical coherence tomography angiography in exudative age-related macular degeneration: a predictive model for treatment decisions. Br J Ophthalmol. 2019;103(9):1342–6.

PubMed  Article  Google Scholar 

Mastropasqua L, Toto L, Borrelli E, Carpineto P, Di Antonio L, Mastropasqua R. Optical coherence tomography angiography assessment of vascular effects occurring after aflibercept intravitreal injections in treatment-naive patients with wet age-related macular degeneration. Retina. 2017;37(2):247–56.

PubMed  Article  Google Scholar 

Miere A, Butori P, Cohen SY, Semoun O, Capuano V, Jung C, et al. Vascular remodeling of choroidal neovascularization after anti-vascular endothelial growth factor therapy visualized on optical coherence tomography angiography. Retina. 2019;39(3):548–57.

CAS  PubMed  Article  Google Scholar 

Woronkowicz M, Lightman S, Tomkins-Netzer O. The prognostic value of total macular external limiting membrane and ellipsoid zone damage for clinical outcome in treatment-resistant neovascular age-related macular degeneration. Graefes Arch Clin Exp Ophthalmol. 2020;258(11):2373–8.

CAS